Poland· PL-100261045
Polibiotic
A other antibiotics for topical use product containing neomycini sulfas + polimyxini b sulfas + bacitracinum zincum, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Neomycini sulfas + polimyxini b sulfas + bacitracinum zincum is registered in 4 of 19 countries.
Countries holding a registration under ATC D06AX (other antibiotics for topical use), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Neomycini sulfas + polimyxini b sulfas + bacitracinum zincum · ATC D06AX
4 / 19 countries
- Belgiumprice
- Czechiaprice
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Neomycini sulfas + Polimyxini B sulfas + Bacitracinum zincum
- Manufacturer
- Aflofarm Farmacja Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- D06AX
- ATC class
- Other antibiotics for topical use
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990915408
- gtin05909990915422
- gtin05909990915439
- gtin05906071034423
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Neomycini sulfas + polimyxini b sulfas + bacitracinum zincum in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb674a06-6c34-4caa-b89b-7b615d02d409 GET /v1/drugs/cb674a06-6c34-4caa-b89b-7b615d02d409?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "(5 mg + 5000 j.m. + 400 j.m.)/g",
"packaging": "05909990915408 ¦ OTC ¦ 71005\n1 tuba 3 g\n05909990915422 ¦ OTC ¦ 71006\n1 tuba 5 g\n05909990915439 ¦ OTC ¦ 71007\n1 tuba 15 g\n05906071034423 ¦ OTC ¦ 108376\n10 sasz. 1 g",
"substance": "Neomycini sulfas 5,0 mg/1 g + Polimyxini B sulfas 5000 j.m./1 g + Bacitracinum zincum 400 j.m./1 g",
"common_name": "Neomycini sulfas + Polimyxini B sulfas + Bacitracinum zincum",
"pl_product_id": "100261045",
"pozwolenie_nr": "18792",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about neomycini sulfas + polimyxini b sulfas + bacitracinum zincum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.